Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients
A Amery, R Fagard, R Fiocchi, P Lijnen… - Journal of …, 1984 - journals.lww.com
Abstract Ketanserin (3× 40 mg daily) was administered during 6 weeks in 14 patients with
mild to moderate essential hypertension using a double-blind, placebo-controlled, crossover …
mild to moderate essential hypertension using a double-blind, placebo-controlled, crossover …
Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients
A Amery, R Fagard, R Fiocchi… - Journal of …, 1984 - pubmed.ncbi.nlm.nih.gov
Ketanserin (3 X 40 mg daily) was administered during 6 weeks in 14 patients with mild to
moderate essential hypertension using a double-blind, placebo-controlled, crossover …
moderate essential hypertension using a double-blind, placebo-controlled, crossover …
Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
A Amery, R Fagard, R Fiocchi, P Lijnen… - Journal of …, 1984 - europepmc.org
Ketanserin (3 X 40 mg daily) was administered during 6 weeks in 14 patients with mild to
moderate essential hypertension using a double-blind, placebo-controlled, crossover …
moderate essential hypertension using a double-blind, placebo-controlled, crossover …